(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SAB SIGNALWAY ANTIBODY

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

SAB SIGNALWAY ANTIBODY

ST13

US500000077783333

Class

1, 5

Filing

77783333

Registration

3830540

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

27

Latest update

07/29/2020

Trademark type

Combined

Nice classes

1, 5

Filing date

07/17/2009

Registration date

08/10/2010

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/28/2020

Last transaction

07/28/2020

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

05/31/2007

First use in commerce

12/31/2007

Drawing code

3

Owner type

16

Owner location

Nanjing, CN

Examiner

OH,WON TEAK

Law office

M50

Current location

GENERIC WEB UPDATE

Mark description

The mark consists of two wings with the letters "SAB" to the right of the wings, a line below the wings and letters "SAB" and the wording "Signalway Antibody" below the line.

Holders and representatives

Holders

NANJING CHUANBO BIOTECH CO., LTD.

Representatives

Zhi Dong Hamre Schumann Mueller & Larson, P.C.

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Antibody for biotech researchphospho-antibodynon-phospho-antibodysecondary antibodytag antibodyblocking peptide; antibody kitELISA kit comprised of protein and IHC kit comprised of protein for life science research; antibody array for life science research

Class 5

Antibody for diagnosis and pharmaceutical developmentphospho-antibodynon-phospho-antibodysecondary antibodytag antibodyblocking peptide

Publications

History of USPTO decisions and trademark events.

27 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

07/29/2020

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

07/28/2020

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

07/28/2020

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/25/2020

E89R

TEAS SECTION 8 & 9 RECEIVED

05/21/2020

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

08/10/2019

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/25/2016

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

12/10/2015

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

12/10/2015

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/10/2015

E815

TEAS SECTION 8 & 15 RECEIVED

10/16/2015

R.PR

REGISTERED-PRINCIPAL REGISTER

08/10/2010

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/25/2010

PUBO

PUBLISHED FOR OPPOSITION

05/25/2010

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

04/17/2010

ALIE

ASSIGNED TO LIE

04/17/2010

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/01/2010

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/16/2010

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/16/2010

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/16/2010

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

10/26/2009

GNRT

NON-FINAL ACTION E-MAILED

10/26/2009

CNRT

NON-FINAL ACTION WRITTEN

10/26/2009

DOCK

ASSIGNED TO EXAMINER

10/20/2009

MDSM

NOTICE OF DESIGN SEARCH CODE MAILED

07/22/2009

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/21/2009

NWAP

NEW APPLICATION ENTERED

07/21/2009

Continuous trademark protection

Get notified about every new filing that threatens SAB SIGNALWAY ANTIBODY or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.